X Linked Hypophosphatemia clinical trials

Explore recruiting x linked hypophosphatemia clinical trials.

Recruiting x linked hypophosphatemia studies right now

Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

X Linked Hypophosphatemia trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A Multicenter, Open-label, Phase 1/2, Dose-escalation and Subsequent Safety Extension Study of Subcutaneous KK8123 in Adult Patients with X-linked Hypophosphatemia

Germany, Spain, France

Human Pharmacology (Phase I)- First administration to humans EU CTIS Study details

X Linked Hypophosphatemia trials by city

X Linked Hypophosphatemia in Toronto X Linked Hypophosphatemia in Vancouver X Linked Hypophosphatemia in Montreal X Linked Hypophosphatemia in Calgary X Linked Hypophosphatemia in Edmonton X Linked Hypophosphatemia in Ottawa X Linked Hypophosphatemia in Winnipeg X Linked Hypophosphatemia in Quebec City X Linked Hypophosphatemia in Hamilton X Linked Hypophosphatemia in Kitchener X Linked Hypophosphatemia in London X Linked Hypophosphatemia in Halifax X Linked Hypophosphatemia in New York X Linked Hypophosphatemia in Los Angeles X Linked Hypophosphatemia in Chicago X Linked Hypophosphatemia in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease